<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(13)</volume><submitter>Liu N</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Diabetic cardiomyopathy (DC), a frequent complication of type 2 diabetes mellitus (T2DM), is mainly associated with severe adverse outcomes. Previous research has highlighted the role of Lysophosphatidylcholine (LPC) in inducing myocardial injury; however, the specific mechanisms through which LPC mediate such injury in DC remain elusive. The existing knowledge gap underscores the need for additional clarification. Consequently, this study aimed to explore the impact and underlying mechanisms of LPC on myocardial injury in DC.&lt;h4>Methods&lt;/h4>A total of 55 patients diagnosed with T2DM and 62 healthy controls were involved. A combination of 16s rRNA sequencing, metabolomic analysis, transcriptomic RNA-sequencing (RNA-seq), and whole exome sequencing (WES) was performed on </pubmed_abstract><journal>Heliyon</journal><pagination>e33601</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11260982</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lysophosphatidylcholine trigger myocardial injury in diabetic cardiomyopathy via the TLR4/ZNF480/AP-1/NF-kB pathway.</pubmed_title><pmcid>PMC11260982</pmcid><pubmed_authors>Deng R</pubmed_authors><pubmed_authors>Zhen X</pubmed_authors><pubmed_authors>Liu N</pubmed_authors><pubmed_authors>Dou J</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Jiang G</pubmed_authors><pubmed_authors>Tao S</pubmed_authors><pubmed_authors>Lv B</pubmed_authors><pubmed_authors>Lu C</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Chang Z</pubmed_authors><pubmed_authors>An T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lysophosphatidylcholine trigger myocardial injury in diabetic cardiomyopathy via the TLR4/ZNF480/AP-1/NF-kB pathway.</name><description>&lt;h4>Background&lt;/h4>Diabetic cardiomyopathy (DC), a frequent complication of type 2 diabetes mellitus (T2DM), is mainly associated with severe adverse outcomes. Previous research has highlighted the role of Lysophosphatidylcholine (LPC) in inducing myocardial injury; however, the specific mechanisms through which LPC mediate such injury in DC remain elusive. The existing knowledge gap underscores the need for additional clarification. Consequently, this study aimed to explore the impact and underlying mechanisms of LPC on myocardial injury in DC.&lt;h4>Methods&lt;/h4>A total of 55 patients diagnosed with T2DM and 62 healthy controls were involved. A combination of 16s rRNA sequencing, metabolomic analysis, transcriptomic RNA-sequencing (RNA-seq), and whole exome sequencing (WES) was performed on </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-01T20:38:06.851Z</modification><creation>2025-05-18T13:26:35.401Z</creation></dates><accession>S-EPMC11260982</accession><cross_references><pubmed>39040275</pubmed><doi>10.1016/j.heliyon.2024.e33601</doi></cross_references></HashMap>